Following completion of this simulation, learners should be able to: Compare and contrast different treatment strategies for managing kidney cancer. Develop individualized treatment plans for patients with kidney cancer based on disease stage, histology, treatment history, and risk group. Recognize, proactively mitigate, and effectively manage immune-related adverse events in patients with kidney cancer who have received immune checkpoint inhibitors. Apply the current recommendations and key updates in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) to optimize the care of patients with kidney cancer. Evaluate new, emerging, and novel therapeutic agents and treatment strategies and incorporate these into the treatment of patients with kidney cancer. Communicate with members of the interprofessional oncology care team to improve collaborative performance in the care of patients with kidney cancer.
- Provider:National Comprehensive Cancer Network
- Activity Link: https://nccn.education.org
- Start Date: 2024-12-01 06:00:00
- End Date: 2024-12-01 06:00:00
- Credit Details: AAPA Category 1 Credit™️: 1.5 hours
AMA PRA Category 1 Credit™️: 1.5 hours
Optometry: 1.5 hours
Pharmacy: 1.5 hours - MOC Credit Details: ABS - 1.5 Point; Credit Type(s): Accredited CME (ABS)
ABPATH - 1.5 Point; Credit Type(s): Lifelong Learning (ABPATH)
ABIM - 1.5 Point; Credit Type(s): Medical Knowledge (ABIM) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
- Provider Ship: Jointly Provided
- Registration: Open to all
- Specialty: Complex General Surgical Oncology, Medical Oncology, Renal/Medical Renal